Tazarotene
- Product NDC
- 68308-745
- 11-digit product format
- 683080745
- Labeler code
- 68308
- Product ID
- 68308-745_fa8e7930-3ff4-44d5-8978-0bcabcd6e26f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TAZAROTENE
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Mayne Pharma
- Application
- ANDA208662
- Marketing category
- ANDA
- Marketing start
- 2021-11-10
- Substance
- TAZAROTENE
- Active strength
- 1 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tazarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAZAROTENE | 1 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 81BDR9Y8PS |
DailyMed Product Concepts#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68308-745-30 | 68308074530 | 1 TUBE in 1 CARTON (68308-745-30) / 30 g in 1 TUBE | 1 tube | 2021-11-10 | 0000-00-00 | No | No | Current |
| 68308-745-60 | 68308074560 | 1 TUBE in 1 CARTON (68308-745-60) > 60 g in 1 TUBE | 1 tube | 2021-11-10 | 0000-00-00 | No | No | Current |